Submissions

Author Guidelines

Author Fees = $0.  

All submissions are free-of-charge. There is no fee to submit a manuscript, nor is there any fee to publish the manuscipt if the manuscript is accepted for publication.  Eye Reports believes that authors, who have already worked hard to develop and prepare new and novel material for dissemination to the scientific community, should not have to bear the burden of additional financial expenses; therefore, we do not charge authors any expense in publishing accepted works.

 

To submit a new paper to Eye Reports:

1. Register as an Author; we encourage you to register also as a Reader and a Reviewer at the same time;
2. Follow the Guidelines for Authors (see below);
3. Read our Editorial Policies and our Competing Interest policies.

To submit a revised version:

1. Log in;
2. Click on your role as Author;
3. Click on IN REVIEW: REVISIONS REQUIRED or RESUBMIT FOR REVIEW on the page displayed (under the heading ‘Status’, near the manuscript title);
4. Under the heading EDITOR DECISION, upload your revised paper as AUTHOR VERSION using Browse and Upload buttons;
5. Use the NOTIFY EDITOR e-mail button to inform the Editors that the revised version has been submitted.

Guidelines for Authors

Manuscripts must be double-spaced with one-inch margins. Headings must be used to designate the major divisions of the paper. To facilitate the review process, manuscripts should contain page and line numbering.
Manuscripts must be written in English. Authors whose native language is not English are strongly advised to have their manuscript checked by a language editing service, or by an English mother-tongue colleague prior to submission. As an option, Eye Reports offers its own professional copyediting service (for an additional fee - please inquire with the journal manager by sending an email to manager@eyereports.org). Professional copyediting can help authors improve the presentation of their work and increase its chances of being accepted. In case you feel that your manuscript needs a professional English language copyediting checking language grammar and style, Eye Reports offers a rapid-turnaround revision service for an additional fee. Please contact us (email to manager@eyereports.org) to get more detailed information on this service.

The first page must contain: i) title (lowercase), without acronyms; ii) first name and family name of each author, separated by commas; iii) affiliation(s) of each author; iv) acknowledgments; v) full name and full postal address of the corresponding author. Phone, fax number and e-mail address for the correspondence should also be included; and, vi) three to five key words. The second page should contain: i) authors’ contributions, e.g., information about the contributions of each person named as having participated in the study (http://www.icmje.org/#author); ii) disclosures about potential conflict of interests; iii) further information (e.g., funding, conference presentation ...).

If tables are used, they should be double-spaced on separate pages. They should be numbered and cited in the text of the manuscript.

If figures are used, they must be submitted as .tif or .jpg files, with the following digital resolution:
i) color (saved as CMYK or RGB): minimum 300 dpi;
ii) black and white/grays: minimum 600 dpi;
iii) one column width (8.5 cm) or 2 column widths (17.5 cm).
A different caption for each figure must be provided at the end of the manuscript, not included in the figure file.

If abbreviations are used in the text, authors are required to write full name+abbreviation in brackets [e.g. Multiple Myeloma (MM)] the first time they are used, then only abbreviations can be written (apart from titles; in this case authors have to write always the full name).

Original Articles (3500 words max, abstract 180 words max, 30 references max, 3/5 tables and/or figures): In general, this kind of publication should be divided into an Abstract, Introduction, Materials and Methods, Results, Discussion, Conclusions and References. A maximum of 10 authors is permitted and additional authors should be listed in an ad hoc Appendix.
Reviews (4000 words max, abstract 250 words max, minimum 40 references, 3/5 tables and/or figures): They should be introduced by a general summary of content in the form of an Abstract. Following a short introduction, putting the study into context and defining the aim, reviews will concentrate on the most recent developments in the field. A review should clearly describe the search strategy followed (key words, inclusion, exclusion criteria, search engines, ...). No particular format is required; headings should be used to designate the major divisions of the paper.
Brief Reports (about 2000 words, abstract 150 words max, 20 references max, 3 tables and/or figures): Short reports of results from original researches. They should be introduced by a general summary of content in the form of an Abstract. They must provide conclusive findings: preliminary observations or incomplete findings cannot be considered for publication.
Case Reports (about 2000 words, abstract 150 words max, 20 references max, 3 tables and/or figures): Reports describing observations on clinical cases that can be educational, including adverse effects of drugs or outcomes of a specific treatment. They should be divided into: Abstract, Introduction (optional), Case report(s), Discussion, Conclusions and References.
Letters to the Editor (800 words max): These are written on invitation, short essays that express the authors’ viewpoint, may respond to published manuscripts in our journals, or deliver information or news regarding an issue related to the Journal scope. If the letter relates to a published manuscript, the authors of the original manuscript will be given the opportunity to provide a respond. Authors of Letters to the Editor should provide a short title.
Book Reviews (no abstract, no references needed): They should be a short critical analysis and evaluation of the quality, meaning, and significance of a short book which addressed at least one of main topics of the Journal.
For further details on the specific layout to follow for the different types of papers published by the Journal, please refer to the Section Policies.

References

References should be prepared strictly according to the Vancouver style. References must be numbered consecutively in the order in which they are first cited in the text (not alphabetical order), and they must be identified in the text by Arabic numerals in superscript. References in the main text must always be cited after dots and commas. References to personal communications and unpublished data should be incorporated in the text and not placed under the numbered references [Example: (Wright 2011, unpublished data) or (Wright 2011, personal communication)]. Where available, URLs for the references should be provided directly within the MS-Word document. References in the References section must be prepared as follows:
i) more than three authors, cite 3 authors, et al. If the paper has only 4 authors, cite all authors;
ii) title style: sentence case; please use a capital letter only for the first word of the title;
iii) journal titles mentioned in the References list should be abbreviated according to the following websites:
a. ISI Journal Abbreviations Index (http://library.caltech.edu/reference/abbreviations/);
b. Biological Journals and Abbreviations (http://home.ncifcrf.gov/research/bja/);
c. Medline List of Journal Titles (ftp://ftp.ncbi.nih.gov/pubmed/J_Medline.txt);
iv) put year after the journal name;
v) never put month and day in the last part of the references;
vi) cite only the volume (not the issue in brackets);
vii) pages have to be abbreviated, e.g., 351-8.

To ensure the correct citation format, please check your references in the PubMed database (http://www.ncbi.nlm.nih.gov/pubmed).

Examples:

Standard journal article

Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002;347:284-7.

Proceedings

Christensen S, Oppacher F. An analysis of Koza’s computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, eds. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming, 2002 Apr 3-5, Kinsdale, Ireland. Berlin: Springer; 2002. pp 182-91.

Article with organization as author

Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension 2002;40:679-86.

Books

Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis, MO: Mosby; 2002.

Bjørn Lomborg, ed. RethinkHIV - Smarter ways to invest in ending HIV in Sub-Saharan Africa. Cambridge: Cambridge University Press; 2012.

Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, eds. The genetic basis of human cancer. New York, NY: McGraw-Hill; 2002. pp 93-113.

Peer review policy

All manuscripts submitted to our journal are critically assessed by external and/or in-house experts in accordance with the principles of peer review (http://www.icmje.org/#peer), which is fundamental to the scientific publication process and the dissemination of sound science. Each paper is first assigned by the Editors to an appropriate Associate Editor who has knowledge of the field discussed in the manuscript. The first step of manuscript selection takes place entirely in-house and has two major objectives: i) to establish the article’s appropriateness for our journals’ readership; ii) to define the manuscript’s priority ranking relative to other manuscripts under consideration, since the number of papers that the journal receives is much greater than it can publish. If a manuscript does not receive a sufficiently high priority score to warrant publication, the editors will proceed to a quick rejection. The remaining articles are reviewed by at least two different external referees (second step or classical peer review). Manuscripts should be prepared according to the Uniform Requirements established by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/#prepare).

Authorship: all persons designated as authors should qualify for authorship according to the ICMJE criteria (http://www.icmje.org/ethical_1author.html). Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should only be based on substantial contributions to i) conception and design, or analysis and interpretation of data; and to ii) drafting the article or revising it critically for important intellectual content; and on iii) final approval of the version to be published. These three conditions must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author. Authors should provide a brief description of their individual contributions.

Obligation to Register Clinical Trials (http://www.icmje.org/#clin_trials): the ICMJE believes that it is important to foster a comprehensive, publicly available database of clinical trials. The ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or concurrent comparison or control groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Medical interventions include drugs, surgical procedures, devices, behavioral treatments, process-of-care changes, etc. Our journals require, as a condition of consideration for publication, registration in a public trials registry. The journal considers a trial for publication only if it has been registered before the enrollment of the first patient. The journal does not advocate one particular registry, but requires authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a non-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include a minimum of data elements (http://www.icmje.org/#clin_trials). For example, ClinicalTrials.gov (http://www.clinicaltrials.gov), sponsored by the United States National Library of Medicine, meets these requirements.

Protection of Human Subjects and Animals in Research: when reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national) and with the Helsinki Declaration of 1975 (as revised in 2008). In particular, PAGEPress adopts the WAME policy on Ethics in Research (http://www.wame.org). Documented review and approval from a formally constituted review board (Institutional Review Board - IRB - or Ethics committee) is required for all studies (prospective or retrospective) involving people, medical records, and human tissues. When reporting experiments on animals, authors will be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.